Pressure Mounts On EU To Follow US In Backing COVID-19 Vaccine IP Waiver
European Industry Bodies Go On The Offensive
The pharmaceutical industry in Europe has attacked the US decision to come out in support of a relaxation of IP rights that is designed to boost global production of COVID-19 vaccines. But the move by the Biden administration could well cause other countries to rethink their opposition to the move.
